In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

AZ and the Karolinska Institute create new research center for cardiometabolic and regenerative med development

Executive Summary

Twice in one day, AstraZeneca PLC announced plans to boost the company’s drug development efforts for cardiometabolic diseases. The first was with Moderna Therapeutics, and the second, with long-time partner the Karolinska Institute, additionally focuses on regenerative medicine.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register